Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Liquid Biopsy Products Market Report 2026-2031 Featuring Analysis of Roche, Illumina, Qiagen, MDxHealth, Novogen, BGI, Myriad Genetics and More

globenewswire.com
ILMN Illumina is listed as a company analyzed in the liquid biopsy market report. The market is expected to grow significantly, driven by precision oncology and advanced molecular diagnostics. No specific sentiment is expressed for Illumina. QGEN Qiagen is mentioned as a company within the liquid biopsy product market. The market is projected to grow due to demand for non-invasive diagnostics and personalized medicine. The article does not offer specific sentiment for Qiagen. MDXH MDxHealth is listed as a company profiled in the liquid biopsy market report. The market is experiencing growth driven by technological advancements and increasing applications in cancer diagnostics. No specific sentiment is attributed to MDxHealth. BGI BGI is mentioned as a company analyzed in the context of the growing liquid biopsy market. The market's expansion is fueled by demand for non-invasive diagnostics and personalized medicine. No specific sentiment is directed at BGI. MYGN Myriad Genetics is listed as a company within the liquid biopsy product market analysis. The market is expected to grow due to advancements in molecular diagnostics and precision oncology. The article provides no specific sentiment for Myriad Genetics.

Liquid Biopsy Products Market Report 2026-2031 Featuring Analysis of Roche, Illumina, Qiagen, MDxHealth, Novogen, BGI, Myriad Genetics and More Dublin, March 20, 2026 (GLOBE NEWSWIRE) -- The "Liquid Biopsy Product Market Report: Trends, Forecast and Competitive Analysis to 2031" has been added to ResearchAndMarkets.com's offering.

The global liquid biopsy product market is expected to grow with a CAGR of 12.4% from 2025 to 2031. The major drivers for this market are the increasing demand for non-invasive cancer diagnostics, the rising adoption of precision oncology testing, and the growing investment in advanced molecular diagnostics.

Key Highlights by Segment

Emerging Trends in the Liquid Biopsy Product Market

The liquid biopsy product market is undergoing significant transformation driven by technological advancements, a shift towards personalized medicine, and increasing demand for minimally invasive diagnostics. Key trends shaping the market include:

In summary, these trends are driving adoption and transforming patient care by improving diagnostic accuracy and expanding clinical applications.

Recent Developments in the Liquid Biopsy Product Market

The liquid biopsy product market continues to advance with notable developments such as improvements in detection methods using NGS and digital PCR, expanding disease applications, and the integration of AI and big data for better diagnostics. Additionally, the emergence of companion diagnostics and growing clinical settings are pivotal. Collectively, these innovations enhance reliability and accessibility while broadening the market's scope.

Strategic Growth Opportunities in the Liquid Biopsy Product Market

Exciting growth opportunities abound in various fields including oncology, prenatal testing, and infectious disease detection, driven by the benefits of minimally invasive diagnostics. Personalized medicine and companion diagnostics offer further potential, with each enhancing clinical outcomes and treatment precision.

Liquid Biopsy Product Market Drivers and Challenges

Market growth is propelled by advancements in molecular diagnostics and personalized medicine, increasing healthcare expenditure, and favorable regulatory conditions. However, challenges include high costs, technical limitations, and complex regulatory landscapes. Addressing these challenges is paramount for advancing market potential and ensuring broader clinical adoption.

Country-Wise Outlook for the Liquid Biopsy Product Market

Geographical variations affect market growth due to factors like healthcare infrastructure and regulatory environments:

Overall, countries are investing in R&D to harness the potential of liquid biopsies, with each contributing to global market expansion through innovation and strategic collaborations.

Companies Profiled:

For more information about this report visit https://www.researchandmarkets.com/r/k4y42j

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.